CROI: Preventive HIV Therapy May Limit Options for Women

Courtesy MedPage Today Infectious Disease  Wed, 02/11/2009 - 08:48

MONTREAL (MedPage Today) -- Exposure to a single dose of an anti-HIV drug to prevent mother-to-child transmission may close off future treatment options for the mother, a researcher found.


 

More related items

Viramune HIV Infant Prophylaxis Safe (CME/CE)
(MedPage Today) -- An anti-HIV drug used to prevent mother-to-child transmission of the virus can be safely and effectively given to newborns for up to six months after birth, researchers...

ICAAC: New Drug Easier to Take than HIV Standard...
CHICAGO (MedPage Today) -- The recently approved HIV drug rilpivirine (Edurant) is easier to take for the first three months of therapy than the widely used efavirenz (Sustiva), a researcher...

Untreated HIV Patients Have New Drug Option (CME/CE)
(MedPage Today) -- The recently approved anti-HIV drug rilpivirine (Edurant) is a new option for people starting treatment for the virus, according to investigators on two randomized...

Burt's Bees - Baby Bee Buttermilk Lotion, 7 fl oz...
Baby Bee Buttermilk Lotion contains only Mother Nature's safe and gentle ingredients, and is enriched with vitamin E, Aloe Vera and Buttermilk to provide soothing and nourishing emollients...

ghd MK4 Professional Advanced Ceramic Heat-Styler, 1"
Endorsed by the world's top session stylists and hottest celebrities, the revolutionary, professional ghd MK4 original ceramic styling iron is everybody's number one must-have beauty...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com